Developer docs
API playgroundTry for free, no card

Search company profiles

Canopy Clinical Research

Full company profile

uuid02lycvj

Namestring
Canopy Clinical Research
Legal namestring
Canopy Clinical Research
Websiteurl
canopycr.com.au
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Canopy Clinical Research is an Australian multi-site private clinical trials network founded in 2020, operating Phase I through Phase IV studies across vaccines, metabolic, cardiovascular, dermatology, respiratory, oncology, and other therapeutic areas. The company runs four operational sites in Brookvale (NSW), Miranda (NSW), Wollongong (NSW) and Altona North (VIC), with a newly opened Inner West site in Leichhardt (May 2026) and a Western Sydney site at Penrith in development. The network is equipped with GCP-compliant workflows, calibrated on-site equipment (ECG, spirometry, -80°C freezers, PC1 lab rooms), and is supported by a pre-screened participant database of 38,000+ individuals managed by a dedicated central recruitment and retention team.

The core product is site-based clinical trial services delivered to pharmaceutical sponsors, biotechnology companies, and CROs, augmented by two sub-brands: Canopy Cancer Care (oncology research, partnered with Cancer Care Associates) and Canopy Consulting (advisory for biotechs entering Australia). Technology infrastructure includes the Clinrol Connect patient engagement and recruitment platform, which applies AI-based patient prioritisation and integrates with Canopy's CTMS, alongside GP referral workflows compatible with Best Practice and Medical Director software.

Revenue is generated on a project basis from individual study contracts negotiated with sponsors and CROs (50+ sponsors and 15+ CRO partners named, including Novartis, Moderna, Novavax, GSK, Merck, Novo Nordisk, PPD, ICON, and Novotech). Pricing is not publicly disclosed and is negotiated per study. The go-to-market combines direct enterprise sales (CEO and Head of Business Development attend BIO, ADA, and GPCE conferences), a community-led GP/specialist referral network, event-driven awareness, and direct-to-consumer participant recruitment through digital channels and a Consumer Advisory Panel. The leadership team is drawn heavily from senior roles at global top-5 CROs and major pharmaceutical companies, which is the company's principal differentiating talent asset.

Short descriptiontext

Canopy Clinical Research is an Australian multi-site private clinical trials network founded in 2020, conducting Phase I-IV studies for pharmaceutical, biotech, and CRO sponsors across multiple therapeutic areas including oncology, metabolic, and cardiovascular. It operates across NSW and Victoria with a 38,000+ pre-screened participant database.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersBrookvale, Australia
HQ citystring
Brookvale
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices6 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial services, patient recruitment, contract research site, oncology research, vaccine clinical studies
Industry2 codes
PRIMARYHLAGACAA
Site Network Operators & SMOs
SECONDARYHLAGACAD
Clinical Trial Patient Recruitment & Retention
NAICS code2 codes
  • Medical and Diagnostic Laboratories6215
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Research Site Network Services
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Trial Services for Sponsors
TypeProfessional Services
Description

Canopy Clinical conducts Phase I through Phase IV clinical trials on behalf of pharmaceutical, biotechnology companies, and CROs. Sponsors pay for site services including participant recruitment, study execution, data collection, and regulatory compliance. Revenue is project-based, tied to individual trial contracts with milestones.

canopycr.com.au
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 2 records shown
1Canopy Consulting
Description

Consulting service partnering with biotechs and sponsors considering Australia to run their clinical trials, offering CRO selection, regulatory navigation, and trial oversight support.

canopycr.com.au
+1 more record
Core offering1 text field

Canopy Clinical Research operates a multi-site private clinical trials network that conducts Phase I (non-confinement) through Phase IV trials for pharmaceutical, biotechnology, and CRO sponsors across Australia. It recruits participants through a 38,000+ pre-screened database and delivers oncology (Canopy Cancer Care) and consulting (Canopy Consulting) services alongside its core site network.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Met or exceeded recruitment targets on >90% of trials performed to date, and was the top recruiter for 80% of those trials
+3 more records
Product overview1 text field

Canopy Clinical Research is a multi-site private clinical trials network operating as a unified platform with specialized sub-brands and services. The core offering consists of Phase I through Phase IV clinical trial services across six locations in Australia. Supporting the core clinical trials business are two key sub-brands: Canopy Cancer Care (oncology research services) and Canopy Consulting (strategic consulting for biotechs and sponsors). The company also offers individual clinical trials including studies in oncology (PEAK-1), metabolic/weight management (multiple programs), cardiovascular (hypertension, atherosclerosis), respiratory (asthma), dermatology (venous leg ulcers, toenail fungal infection), musculoskeletal (osteoarthritis, gout), diabetes, neurology (migraine, panic disorder), and gastroenterology (coeliac disease). The network's infrastructure includes the Clinrol patient recruitment technology platform for streamlined operations.

Product and service3 records
1Canopy Clinical Research - Clinical Trial Services
CategoryClinical Trial Site Services
Description

Multi-site private clinical trials network conducting Phase I (non-confinement) through Phase IV clinical trials for pharmaceutical, biotechnology, and CRO sponsors across therapeutic areas including vaccines, metabolic, cardiovascular, sexual health, dermatology, and mental health.

2Canopy Cancer Care
CategoryOncology Clinical Research
Description

Oncology research service focused on bringing leading global clinical trials closer to people living with cancer across Australia, partnering with cancer care networks, hospitals, and specialists.

3Canopy Consulting
Scale indicator14 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-06-19
Description

Canopy Clinical Research selected Clinrol as its preferred patient recruitment technology platform for select clinical trial studies across its five locations. Clinrol Connect serves as the recruitment layer across Canopy's operations, centralising patient engagement, pre-screening, communication and workflow management while integrating with their CTMS. Features include consolidating call handling, automating reminders and rescheduling, structured phone screening with live eligibility checks, and AI-based patient prioritisation. Implementation was conducted across live studies, allowing workflows to be tested in real-world conditions.

2Cancer Care Associates
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership focused on expanding access to high-quality oncology clinical trials and investigational therapies for people living with cancer, bringing research opportunities closer to home without the burden of travelling far from support networks. Canopy's oncology nursing team and Cancer Care Associates' specialist network collaborate on patient identification and trial delivery.

canopycr.com.au
Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeOthers
Description

Global CRO with owned site network and site-management services in Australia; comparable to Canopy as both a CRO partner channel and a competitive site operator.

TypeDirect peer
Description

Sydney-based early-phase clinical trials unit, directly comparable to Canopy as a private Australian site running Phase I trials for global sponsors.

TypeDirect peer
Description

Adelaide-based independent clinical trial site, comparable to Canopy as an Australian-owned SMO serving international pharma sponsors across multiple therapeutic areas.

TypeDirect peer
Description

Perth-based early-phase clinical trials unit, comparable to Canopy as an Australian site operator running Phase I trials for global pharma and biotech sponsors.

TypeBroad incumbent
Description

Global top-5 CRO with significant site operations in Australia; directly comparable as a buyer of trial site services, and as a competitor when sponsors prefer integrated CRO+site solutions.

TypeBroad incumbent
Description

Global CRO with established Australia presence and strong biotech sponsor relationships, comparable to Canopy as a clinical development partner for sponsors entering Australia.

TypeEmerging player
Description

US-headquartered integrated site network rapidly expanding internationally; comparable to Canopy in being a multi-site SMO serving large pharma, though at materially greater scale.

TypeDirect peer
Description

Australian clinical trial site network focused on outpatient and investigator-led research, comparable in operating model to Canopy's multi-therapeutic site network.

TypeDirect peer
Description

Australian clinical trial site network specialising in early-phase (Phase I) healthy volunteer and patient studies, directly comparable to Canopy's Phase I–IV site operations in Australia.

TypeDirect peer
Description

APAC-focused CRO headquartered in Australia with extensive site management and clinical operations across the region; comparable to Canopy as both a CRO partner and a competitor for Australia-based trial execution.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers11 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Canopy Clinical Research

Clinical Research Site Network Servicescanopycr.com.au

Canopy Clinical Research is an Australian multi-site private clinical trials network founded in 2020, conducting Phase I-IV studies for pharmaceutical, biotech, and CRO sponsors across multiple therapeutic areas including oncology, metabolic, and cardiovascular. It operates across NSW and Victoria with a 38,000+ pre-screened participant database.

What Canopy Clinical Research does

Canopy Clinical Research is an Australian multi-site private clinical trials network founded in 2020, operating Phase I through Phase IV studies across vaccines, metabolic, cardiovascular, dermatology, respiratory, oncology, and other therapeutic areas. The company runs four operational sites in Brookvale (NSW), Miranda (NSW), Wollongong (NSW) and Altona North (VIC), with a newly opened Inner West site in Leichhardt (May 2026) and a Western Sydney site at Penrith in development. The network is equipped with GCP-compliant workflows, calibrated on-site equipment (ECG, spirometry, -80°C freezers, PC1 lab rooms), and is supported by a pre-screened participant database of 38,000+ individuals managed by a dedicated central recruitment and retention team.

The core product is site-based clinical trial services delivered to pharmaceutical sponsors, biotechnology companies, and CROs, augmented by two sub-brands: Canopy Cancer Care (oncology research, partnered with Cancer Care Associates) and Canopy Consulting (advisory for biotechs entering Australia). Technology infrastructure includes the Clinrol Connect patient engagement and recruitment platform, which applies AI-based patient prioritisation and integrates with Canopy's CTMS, alongside GP referral workflows compatible with Best Practice and Medical Director software.

Revenue is generated on a project basis from individual study contracts negotiated with sponsors and CROs (50+ sponsors and 15+ CRO partners named, including Novartis, Moderna, Novavax, GSK, Merck, Novo Nordisk, PPD, ICON, and Novotech). Pricing is not publicly disclosed and is negotiated per study. The go-to-market combines direct enterprise sales (CEO and Head of Business Development attend BIO, ADA, and GPCE conferences), a community-led GP/specialist referral network, event-driven awareness, and direct-to-consumer participant recruitment through digital channels and a Consumer Advisory Panel. The leadership team is drawn heavily from senior roles at global top-5 CROs and major pharmaceutical companies, which is the company's principal differentiating talent asset.

Canopy Clinical Research firmographics

Firmographics
Name
Canopy Clinical Research
Legal name
Canopy Clinical Research
Website
https://canopycr.com.au
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
51–100 employees
Short description
Canopy Clinical Research is an Australian multi-site private clinical trials network founded in 2020, conducting Phase I-IV studies for pharmaceutical, biotech, and CRO sponsors across multiple therapeutic areas including oncology, metabolic, and cardiovascular. It operates across NSW and Victoria with a 38,000+ pre-screened participant database.
Ownership category
akta.pro rank

Canopy Clinical Research industry classification

Industry
Product category
Clinical Research Site Network Services
NAICS
Medical and Diagnostic Laboratories (6215), Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGACAA
Site Network Operators & SMOs
SECONDARYHLAGACAD
Clinical Trial Patient Recruitment & Retention

Keywords

  • Clinical trial services
  • Patient recruitment
  • Contract research site
  • Oncology research
  • Vaccine clinical studies

Where Canopy Clinical Research is headquartered

Location

Headquarters

HQ city
Brookvale
HQ country
Australia
HQ region
Oceania

Offices6 records

Markets served

Canopy Clinical Research business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Clinical Trial Services for Sponsors: Canopy Clinical conducts Phase I through Phase IV clinical trials on behalf of pharmaceutical, biotechnology companies, and CROs. Sponsors pay for site services including participant recruitment, study execution, data collection, and regulatory compliance. Revenue is project-based, tied to individual trial contracts with milestones.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels8 records

Canopy Clinical Research product offering

Product offering

Core offering

Canopy Clinical Research operates a multi-site private clinical trials network that conducts Phase I (non-confinement) through Phase IV trials for pharmaceutical, biotechnology, and CRO sponsors across Australia. It recruits participants through a 38,000+ pre-screened database and delivers oncology (Canopy Cancer Care) and consulting (Canopy Consulting) services alongside its core site network.

Product overview

Canopy Clinical Research is a multi-site private clinical trials network operating as a unified platform with specialized sub-brands and services. The core offering consists of Phase I through Phase IV clinical trial services across six locations in Australia. Supporting the core clinical trials business are two key sub-brands: Canopy Cancer Care (oncology research services) and Canopy Consulting (strategic consulting for biotechs and sponsors). The company also offers individual clinical trials including studies in oncology (PEAK-1), metabolic/weight management (multiple programs), cardiovascular (hypertension, atherosclerosis), respiratory (asthma), dermatology (venous leg ulcers, toenail fungal infection), musculoskeletal (osteoarthritis, gout), diabetes, neurology (migraine, panic disorder), and gastroenterology (coeliac disease). The network's infrastructure includes the Clinrol patient recruitment technology platform for streamlined operations.

Differentiator

Problem solved

Functional benefit

Brands

  • Canopy Consulting: Consulting service partnering with biotechs and sponsors considering Australia to run their clinical trials, offering CRO selection, regulatory navigation, and trial oversight support.
  • Canopy Cancer Care

Products and services

  • Canopy Clinical Research - Clinical Trial Services Multi-site private clinical trials network conducting Phase I (non-confinement) through Phase IV clinical trials for pharmaceutical, biotechnology, and CRO sponsors across therapeutic areas including vaccines, metabolic, cardiovascular, sexual health, dermatology, and mental health.
  • Canopy Cancer Care Oncology research service focused on bringing leading global clinical trials closer to people living with cancer across Australia, partnering with cancer care networks, hospitals, and specialists.
  • Canopy Consulting

Quantifiable outcome

  • Met or exceeded recruitment targets on >90% of trials performed to date, and was the top recruiter for 80% of those trials
  • +3 more outcomes

Companies that use Canopy Clinical Research

Customer profile

Named customers11 records

Segments4 records

Ideal customer profiles3 records

Canopy Clinical Research technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability3 records

Feature2 records

Canopy Clinical Research partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • ClinrolcoreTechnology or Integration · 19 June 2026Canopy Clinical Research selected Clinrol as its preferred patient recruitment technology platform for select clinical trial studies across its five locations. Clinrol Connect serves as the recruitment layer across Canopy's operations, centralising patient engagement, pre-screening, communication and workflow management while integrating with their CTMS. Features include consolidating call handling, automating reminders and rescheduling, structured phone screening with live eligibility checks, and AI-based patient prioritisation. Implementation was conducted across live studies, allowing workflows to be tested in real-world conditions.
  • Cancer Care AssociatescoreStrategic or Co-development PartnerPartnership focused on expanding access to high-quality oncology clinical trials and investigational therapies for people living with cancer, bringing research opportunities closer to home without the burden of travelling far from support networks. Canopy's oncology nursing team and Cancer Care Associates' specialist network collaborate on patient identification and trial delivery.

Scale indicators14 records

Recent moves9 records

Expansion highlights5 records

Canopy Clinical Research competitors and assessment

Company assessment

Others

  • IQVIA: Global CRO with owned site network and site-management services in Australia; comparable to Canopy as both a CRO partner channel and a competitive site operator.

Direct peers

  • Scientia Clinical Research: Sydney-based early-phase clinical trials unit, directly comparable to Canopy as a private Australian site running Phase I trials for global sponsors.
  • CMAX Clinical Research: Adelaide-based independent clinical trial site, comparable to Canopy as an Australian-owned SMO serving international pharma sponsors across multiple therapeutic areas.
  • Linear Clinical Research: Perth-based early-phase clinical trials unit, comparable to Canopy as an Australian site operator running Phase I trials for global pharma and biotech sponsors.
  • Emeritus Research: Australian clinical trial site network focused on outpatient and investigator-led research, comparable in operating model to Canopy's multi-therapeutic site network.
  • Nucleus Network: Australian clinical trial site network specialising in early-phase (Phase I) healthy volunteer and patient studies, directly comparable to Canopy's Phase I–IV site operations in Australia.
  • Novotech: APAC-focused CRO headquartered in Australia with extensive site management and clinical operations across the region; comparable to Canopy as both a CRO partner and a competitor for Australia-based trial execution.

Broad incumbents

  • ICON plc: Global top-5 CRO with significant site operations in Australia; directly comparable as a buyer of trial site services, and as a competitor when sponsors prefer integrated CRO+site solutions.
  • Parexel: Global CRO with established Australia presence and strong biotech sponsor relationships, comparable to Canopy as a clinical development partner for sponsors entering Australia.

Emerging players

  • Velocity Clinical Research: US-headquartered integrated site network rapidly expanding internationally; comparable to Canopy in being a multi-site SMO serving large pharma, though at materially greater scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Canopy Clinical Research social profiles

Digital presence

Canopy Clinical Research financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Canopy Clinical Research leadership team

Management profile

Number of profiles

Profiles12 records

Canopy Clinical Research funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Canopy Clinical Research M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Canopy Clinical Research

What does Canopy Clinical Research do?

Canopy Clinical Research operates a multi-site private clinical trials network that conducts Phase I (non-confinement) through Phase IV trials for pharmaceutical, biotechnology, and CRO sponsors across Australia. It recruits participants through a 38,000+ pre-screened database and delivers oncology (Canopy Cancer Care) and consulting (Canopy Consulting) services alongside its core site network.

Is Canopy Clinical Research a public or private company?

Canopy Clinical Research is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Canopy Clinical Research founded?

Canopy Clinical Research was founded in 2020. It employs 51 to 100 people.

Where is Canopy Clinical Research based?

Canopy Clinical Research is headquartered in Brookvale, Australia, in the Oceania region.

How does Canopy Clinical Research make money?

One revenue line is on record: clinical Trial Services for Sponsors.

Who are Canopy Clinical Research's main competitors?

IQVIA is listed as an others. Direct peers are Scientia Clinical Research, CMAX Clinical Research, Linear Clinical Research, Emeritus Research, Nucleus Network and Novotech. Broad incumbents are ICON plc and Parexel. Velocity Clinical Research is listed as an emerging player.

Does Canopy Clinical Research have an API?

No public API is recorded for Canopy Clinical Research.

What industry is Canopy Clinical Research in?

Canopy Clinical Research's product category is Clinical Research Site Network Services. Its primary akta.pro industry code is HLAGACAA, Site Network Operators & SMOs, with a secondary code of HLAGACAD, Clinical Trial Patient Recruitment & Retention. Its NAICS code is 6215 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
IT Brief AustraliaCanopy Clinical Research picks Clinrol for recruitmentCanopy Clinical Research selected Clinrol as its preferred patient recruitment technology partner across five locations. The deal makes Canopy one of the first major Australian clinical research site networks to adopt a dedicated recruitment platform separate from its trial management system. The platform consolidates call handling, automates reminders, and uses AI to rank patients by likelihood of qualifying.EcommercenewsCanopy Clinical Research picks Clinrol for recruitmentCanopy Clinical Research selected Clinrol as its preferred patient recruitment technology partner across five locations. The deal makes Canopy one of the first major Australian clinical research site networks to adopt a dedicated recruitment platform separate from its trial management system. The platform consolidates call handling, automates reminders, and uses AI to rank patients by likelihood of qualifying.TelconewsCanopy Clinical Research picks Clinrol for recruitmentCanopy Clinical Research selected Clinrol as its preferred patient recruitment technology partner across five locations. The deal makes Canopy one of the first major Australian clinical research site networks to adopt a dedicated recruitment platform separate from its trial management system. The platform consolidates call handling, automates reminders, and uses AI to rank patients by likelihood of qualifying.CFOtech AustraliaCanopy Clinical Research picks Clinrol for recruitmentCanopy Clinical Research selected Clinrol as its preferred patient recruitment technology partner across five locations. The deal makes Canopy one of the first major Australian clinical research site networks to adopt a dedicated recruitment platform separate from its trial management system. The platform consolidates call handling, automates reminders, and uses AI to rank patients by likelihood of qualifying.